Difficulty: Medium
Average Score: 79%
Practice
Azathioprine:
Correct answer
A
Rationale
Azathioprine is a prodrug, which means it is converted in the body into its active form, 6-mercaptopurine. This active metabolite exerts its immunosuppressive effects by interfering with DNA synthesis, making it an important drug in the management of various autoimmune conditions, including pediatric cardiovascular disorders like Kawasaki disease.
Option B, stating that azathioprine is teratogenic, is incorrect. While azathioprine is classified as Pregnancy Category D due to potential risks, teratogenicity is not a primary concern. It should be used cautiously in pregnancy, but its benefits may outweigh the risks in certain situations.
Option C, suggesting that azathioprine should be avoided in liver disease, is also incorrect. Azathioprine is primarily metabolized by the liver, so dose adjustments may be necessary in patients with liver dysfunction, but it is not an absolute contraindication.
Option D, indicating that the dose of azathioprine should be increased when given with allopurinol, is incorrect. Allopurinol can inhibit the metabolism of azathioprine, leading to increased levels of the active metabolite and potential toxicity. Therefore, the dose of azathioprine should be decreased when used concomitantly with allopurinol.
In an educational context, understanding the pharmacology of azathioprine is crucial for pediatric nurses caring for children with cardiovascular disorders requiring immunosuppressive therapy. Knowing that azathioprine is a prodrug helps nurses understand its mechanism of action and potential adverse effects, guiding safe and effective medication administration.
Option B, stating that azathioprine is teratogenic, is incorrect. While azathioprine is classified as Pregnancy Category D due to potential risks, teratogenicity is not a primary concern. It should be used cautiously in pregnancy, but its benefits may outweigh the risks in certain situations.
Option C, suggesting that azathioprine should be avoided in liver disease, is also incorrect. Azathioprine is primarily metabolized by the liver, so dose adjustments may be necessary in patients with liver dysfunction, but it is not an absolute contraindication.
Option D, indicating that the dose of azathioprine should be increased when given with allopurinol, is incorrect. Allopurinol can inhibit the metabolism of azathioprine, leading to increased levels of the active metabolite and potential toxicity. Therefore, the dose of azathioprine should be decreased when used concomitantly with allopurinol.
In an educational context, understanding the pharmacology of azathioprine is crucial for pediatric nurses caring for children with cardiovascular disorders requiring immunosuppressive therapy. Knowing that azathioprine is a prodrug helps nurses understand its mechanism of action and potential adverse effects, guiding safe and effective medication administration.